← FDA DRUG APPROVALS

FDA NDA · NDA019833

CHILDREN'S ADVIL

Sponsor: HALEON US HOLDINGS

APPLICATION
NDA019833
TYPE
NDA
ORIGINAL APPROVAL
1989-09-19
LATEST ACTION
1998-05-08
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

CHILDREN'S ADVILDiscontinued
IBUPROFEN 100MG/5ML · SUSPENSION · ORAL

Approval history

1998-05-08Manufacturing (CMC) · Supplement 12 · standardAP
1998-01-26Labeling · Supplement 11 · standardReviewAP
1994-10-24Manufacturing (CMC) · Supplement 8 · standardAP
1994-07-27Manufacturing (CMC) · Supplement 2 · standardAP
1994-04-25Manufacturing (CMC) · Supplement 1 · standardAP
1994-04-21Manufacturing (CMC) · Supplement 5 · standardAP
1991-11-27Manufacturing (CMC) · Supplement 7 · standardAP
1989-09-19Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →